HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Torrent Pharma’s consolidated net profit falls 22% in Q4
May-25-2026

Torrent Pharmaceuticals has reported results for the fourth quarter (Q4FY26) and year ended March 31, 2026.

The company has reported 1.48% decline in its net profit at Rs 467.00 crore for the quarter under review as compared to Rs 474.00 crore for the same quarter in the previous year. However, total income of the company has increased by 14.09% at Rs 2,793.00 crore for Q4FY26 as compared to Rs 2,448.00 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 21.89% decline in its net profit at Rs 389.00 crore for the fourth quarter ended March 31, 2026 as compared to Rs 498.00 crore for the same quarter in the previous year. However, total income of the company has increased by 42.13% at Rs 4,180.00 crore for Q4FY26 as compared to Rs 2,941.00 crore for the corresponding quarter previous year.

For the year ended March 31, 2026, the company has reported 16.10% rise in its net profit at Rs 2,192.00 crore as compared to Rs 1,888.00 crore for the previous year. The total income of the company has increased by 10.46% at Rs 10,730.00 crore for year under review as compared to Rs 9,714.00 crore for year ended March 31, 2025.

For the year ended March 31, 2026, on the consolidated basis, the company has reported 13.19% rise in its net profit at Rs 2,163.00 crore as compared to Rs 1,911.00 crore for the previous year. The total income of the company increased by 20.34% at Rs 13,886.00 crore for year under review as compared to Rs 11,539.00 crore for year ended March 31, 2025.

  RELATED NEWS >>